123 related articles for article (PubMed ID: 30944035)
1. Dyslipidaemia is common among patients with type 2 diabetes: a cross-sectional study at Tema Port Clinic.
Ofori EK; Owusu-Ababio D; Tagoe EA; Asare-Anane H
BMC Res Notes; 2019 Apr; 12(1):204. PubMed ID: 30944035
[TBL] [Abstract][Full Text] [Related]
2. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
Ozder A
Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.
Anto EO; Obirikorang C; Annani-Akollor ME; Adua E; Donkor S; Acheampong E; Asamoah EA
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31330902
[No Abstract] [Full Text] [Related]
4. Prevalence of Dyslipidemia and Associated Factors in Obese Children and Adolescents.
Elmaoğulları S; Tepe D; Uçaktürk SA; Karaca Kara F; Demirel F
J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):228-34. PubMed ID: 26831558
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Music M; Dervisevic A; Pepic E; Lepara O; Fajkic A; Ascic-Buturovic B; Tuna E
Med Arch; 2015 Aug; 69(4):251-5. PubMed ID: 26543313
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.
Pokharel DR; Khadka D; Sigdel M; Yadav NK; Acharya S; Kafle R; Sapkota RM; Sigdel T
BMC Res Notes; 2017 Apr; 10(1):146. PubMed ID: 28376848
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of abnormal serum liver enzymes in patients with type 2 diabetes mellitus: a cross-sectional study from China.
Chen S; Guo X; Chen Y; Dong S; Sun Y
Postgrad Med; 2016 Nov; 128(8):770-776. PubMed ID: 27681272
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of abnormal serum alanine aminotransferase levels in type 2 diabetic patients in Iran.
Meybodi MA; Afkhami-Ardekani M; Rashidi M
Pak J Biol Sci; 2008 Sep; 11(18):2274-7. PubMed ID: 19137840
[TBL] [Abstract][Full Text] [Related]
9. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
10. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Chen S; Guo X; Zhang X; Yu S; Yang H; Jiang M; Sun G; Sun Y
BMC Cardiovasc Disord; 2015 Jul; 15():65. PubMed ID: 26160405
[TBL] [Abstract][Full Text] [Related]
11. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.
Sattar N; McConnachie A; Ford I; Gaw A; Cleland SJ; Forouhi NG; McFarlane P; Shepherd J; Cobbe S; Packard C
Diabetes; 2007 Apr; 56(4):984-91. PubMed ID: 17395744
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem.
Belkacemi L; Belalia M
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S147-50. PubMed ID: 26711007
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Genotype Distribution of Hepatitis C Virus Infection among Patients with Type 2 Diabetes Mellitus.
Farshadpour F; Taherkhani R; Ravanbod MR; Eghbali SS
Med Princ Pract; 2018; 27(4):308-316. PubMed ID: 29621783
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
15. [Effects of ursolic acid on liver injury and its possible mechanism in diabetes mellitus mice].
Wang XT; Chen SS; Qi MY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):134-136. PubMed ID: 29926677
[TBL] [Abstract][Full Text] [Related]
16. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
Taskinen MR; Borén J
Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
[TBL] [Abstract][Full Text] [Related]
18. Hb and dyslipidaemia as predicting markers of serum alanine aminotransferase elevation in Chinese adolescents.
Chao KC; Chang CC; Owaga E; Bai CH; Huang TC; Pan WH; Chang JS
Public Health Nutr; 2016 Apr; 19(6):1067-73. PubMed ID: 26328752
[TBL] [Abstract][Full Text] [Related]
19. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
Jin HB; Gu ZY; Yu CH; Li YM
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
Tian F; Zheng Z; Zhang D; He S; Shen J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
